Design and synthesis of JNK1-targeted PROTACs and research on the activity
- 15 December 2024
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 154, 108044
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82373739)
- National Key Research and Development Program of China
This publication has 29 references indexed in Scilit:
- Structure Optimization of c-Jun N-terminal Kinase 1 Inhibitors for Treating Idiopathic Pulmonary FibrosisJournal of Medicinal Chemistry, 2024
- Dehydrocostus lactone inhibits BLM-induced pulmonary fibrosis and inflammation in mice via the JNK and p38 MAPK-mediated NF-κB signaling pathwaysInternational Immunopharmacology, 2021
- Targeting estrogen receptor α for degradation with PROTACs: A promising approach to overcome endocrine resistanceEuropean Journal of Medicinal Chemistry, 2020
- PROTACs: An Emerging Therapeutic Modality in Precision MedicineCell Chemical Biology, 2020
- Design and synthesis of selective degraders of EGFRL858R/T790M mutantEuropean Journal of Medicinal Chemistry, 2020
- Discovery of an AKT Degrader with Prolonged Inhibition of Downstream SignalingCell Chemical Biology, 2020
- Addressing Kinase-Independent Functions of Fak via PROTAC-Mediated DegradationJournal of the American Chemical Society, 2018
- Targeting the C481S Ibrutinib-Resistance Mutation in Bruton’s Tyrosine Kinase Using PROTAC-Mediated DegradationBiochemistry, 2018
- Lessons in PROTAC Design from Selective Degradation with a Promiscuous WarheadCell Chemical Biology, 2018
- MAP kinase activation and apoptosis in lung tissues from patients with idiopathic pulmonary fibrosisThe Journal of Pathology, 2002